NEW YORK (GenomeWeb) – EKF Diagnostics Holdings today announced that the potential purchase of the company's Point-of-Care business by Chinese firm Jinjing has fallen through.

The firm had also received a non-binding preliminary proposal from an unrelated third party for its Clinical Chemistry and Molecular Diagnostics businesses in August, but that proposal has been withdrawn.

Instead, former Alere CEO Ron Zwanziger will now take over as chairman of EKF, while current chairman David Evans will become deputy chairman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.